CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $137,000 | -73.6% | 115,299 | -55.1% | 0.00% | -80.0% |
| Q1 2022 | $519,000 | -36.2% | 256,919 | -14.4% | 0.01% | -52.4% |
| Q4 2021 | $814,000 | -1.3% | 300,203 | +62.4% | 0.02% | +40.0% |
| Q3 2021 | $825,000 | +1.6% | 184,904 | +59.9% | 0.02% | +7.1% |
| Q1 2021 | $812,000 | +374.9% | 115,628 | +294.6% | 0.01% | +180.0% |
| Q3 2020 | $171,000 | -13.6% | 29,300 | 0.0% | 0.01% | -44.4% |
| Q2 2020 | $198,000 | – | 29,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |